Home
Mail
Search
News
Finance
Sport
Lifestyle
Celebrity
Movies
Weather
Mobile
More
Yahoo
Mail
Cryptocurrencies
News
Property
Money
Markets
Industries
Watchlists
My Portfolio
My Screeners
Singapore markets closed
Straits Times Index
3,287.75
-5.38
(-0.16%)
S&P 500
5,071.63
+1.08
(+0.02%)
Dow
38,460.92
-42.77
(-0.11%)
Nasdaq
15,712.75
+16.11
(+0.10%)
Bitcoin USD
63,556.38
-2,878.46
(-4.33%)
CMC Crypto 200
1,350.17
-32.40
(-2.34%)
Ironwood Pharmaceuticals, Inc. (IRWD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.10
-0.21
(-2.53%)
At close: 04:00PM EDT
8.10
0.00
(0.00%)
After hours:
04:20PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
442,735
442,735
410,596
413,753
389,523
Cost of revenue
-
-
0
0
3,136
Gross profit
-
-
410,596
413,753
386,387
Operating expenses
Research development
116,085
116,085
44,265
70,405
88,062
Selling general and administrative
158,314
158,314
115,994
111,133
140,003
Total operating expenses
274,399
274,399
160,259
181,538
228,065
Operating income or loss
168,336
168,336
250,337
232,215
158,322
Interest expense
21,629
21,629
7,598
31,150
29,478
Total other income/expenses net
-1,113,747
-1,113,747
182
-1,134
-21,487
Income before tax
-948,069
-948,069
252,422
200,657
108,861
Income tax expense
83,490
83,490
77,357
-327,791
2,685
Income from continuing operations
-1,031,559
-1,031,559
175,065
528,448
106,176
Net income
-1,002,239
-1,002,239
175,065
528,448
106,176
Net income available to common shareholders
-1,002,239
-1,002,239
175,065
528,448
106,176
Basic EPS
-6.14
-
1.13
3.26
0.67
Diluted EPS
-6.18
-
0.96
3.21
0.66
Basic average shares
154,761
-
154,366
162,245
159,427
Diluted average shares
162,864
-
186,312
164,418
160,655
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.